IDDI LUNCH & LEARN WORKSHOP

October 8, 2019 — October 8, 2019

Museum of Science, Boston, MA

Validating Surrogate Endpoints in Oncology: From Theory to Practice!

IF YOU MISSED OUR LUNCH & LEARN ON VALIDATING SURROGATE ENDPOINTS IN ONCOLOGY, PRESENTATIONS AND RECORDING ARE AVAILABLE HERE :

  • A clinical perspective on surrogate endpoints in prostate cancer
    Prof Christopher Sweeney, MBBS, Professor of Medicine, Harvard Medical School and Medical Oncologist, Dana-Farber Cancer Institute
  • Statistical considerations on surrogate endpoints
    Prof Tomasz Burzykowski, PhD, VP Research IDDI and Professor of Biostatistics, Hasselt University, Belgium
VIEW THE RECORDING HERE

 

WHAT YOU WILL LEARN:

  • The theoretical requirements for validating surrogate endpoints, as currently used by FDA
  • The steps entailed in surrogate validation
  • The difference between patient-level and trial-level surrogacy

 

Surrogates endpoints
Powered by Atypic ®

IDDI